Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

FDA Approves RxSight's Light Adjustable Lens, First IOL To Enable Refractive Correction After Cataract Surgery

ALISO VIEJO, Calif., Nov. 22, 2017 /PRNewswire/ --RxSight, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the RxSight(TM) Light Adjustable Lens and the Light Delivery Device (LDD) for patients with pre-existing astigmatism of >= 0.75 diopters undergoing... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017

Check-Cap Ltd. Announces Closing of $2.5 Million Registered Direct Offering

ISFIYA, Israel and BOSTON, Nov. 22, 2017 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced the... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017

MabVax Announces Adjournment of Special Meeting of Stockholders

SAN DIEGO, Nov. 22, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today announced that its Special Meeting of Stockholders... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  MabVax Therapeutics Holdings, Inc.

Novus Anti-Aging Center, Inc. Offers New ED Treatment near LA

STUDIO CITY, Calif., Nov. 22, 2017 /PRNewswire/ -- Novus Anti-Aging Center, Inc., is pleased to announce they now offer GAINSWave(TM)!... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017

Allergan to Present at the 2017 Citi Global Healthcare Conference

DUBLIN, Nov. 22, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury will present at the 2017 Citi Global Healthcare Conference in New York City. The presentation will begin at 11:45 a.m. Eastern... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  Allergan, Inc. | Allergan, Irvine

Nektar Announces Key Executive Promotions to Drive the Continued Growth of the Company's Immuno-Oncology Pipeline

SAN FRANCISCO, Nov. 22, 2017 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today several promotions on its executive leadership team:

Read more ››
By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  Nektar Therapeutics Inc.

Contract Research Organization Market Analysis: Global Size, Share, Trends, Growth Drivers, Industry Demand, Competitive Landscape and Forecasts to 2021

NEW YORK, Nov. 22, 2017 /PRNewswire-iReach/ -- This latest research report "Global Contract Research Organization (CRO) Market: Size, Trends & Forecasts (2017-2021)", provides analysis of the global contract research organization (CRO) market, with detailed analysis of market size... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017

Dynamic Health Studio Offers New ED Treatment

CALGARY, Alberta, Nov. 22, 2017 /PRNewswire/ -- Dynamic Health Studio, is pleased to announce they now offer GAINSWave(TM)! This... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017

ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX

TSX VENTURE LISTING EXPECTED TO IMPROVE OPERATING EFFICIENCY, LOWER COSTS AND PROVIDE ENHANCED FINANCING FLEXIBILITY

Read more ››
By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  ESSA Pharma Inc.

Nuvo Pharmaceuticals(TM) Announces Appointment of Jesse Ledger as President & Chief Executive Officer

MISSISSAUGA, ON, Nov. 22, 2017 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI), a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced the appointment of Jesse Ledger as its President & Chief... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  Nuvo Pharmaceuticals Inc.

Virbac : Aquaculture: Virbac postpones its option to buy Centrovet for three years

Read more ››
By: Nasdaq / GlobenewsWire - 22 Nov 2017
Related companies:  VIRBAC

Innate Pharma provides an update on Lirilumab

Read more ››
By: Nasdaq / GlobenewsWire - 22 Nov 2017
Related companies:  Innate Pharma S.A. | Innate Immunotherapeutics Limited | Innate Immunotherapeutics Limited

SPINEWAY : Implementation of the SKYWAY 2018 plan

Read more ››
By: Nasdaq / GlobenewsWire - 22 Nov 2017
Related companies:  Spineway

GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor

Read more ››
By: Nasdaq / GlobenewsWire - 22 Nov 2017
Related companies:  Genfit SA | GENFIT Corp

John Imperio is recognized by Continental Who's Who

STATEN ISLAND, N.Y., Nov. 22, 2017 /PRNewswire/ -- John Imperio is recognized by Continental Who's Who as a 2017 Lifetime Member in recognition of his recognitions to the Medical field.

Read more ››
By: PR Newswire Association LLC. - 22 Nov 2017

Dr. Diva De León-Crutchlow, Pediatric Endocrinologist at Children's Hospital of Philadelphia, Honored by Congenital Hyperinsulinism International

PHILADELPHIA, Nov. 22, 2017 /PRNewswire-USNewswire/ -- As a pediatric endocrinologist and director of the Congenital Hyperinsulinism Center at Children's Hospital of Philadelphia (CHOP),... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017

Global Nanocellulose Market 2017-2021 with Borregaard, CelluForce, Daicel, NIPPON PAPER INDUSTRIES, RISE & Sappi Dominating

DUBLIN, November 22, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Intezyne's $10M Series A Preferred Round Wins SEBIO's 'Deal of the Year'

TAMPA, Fla. and BELMONT, N.C., Nov. 22, 2017 /PRNewswire/ -- Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies that is headquartered at the USF Tampa Bay Technology Incubator, announced that its recently closed $10M Series A Preferred round, led by North... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  Intezyne, Inc.

Patient Handling Equipment Market will achieve 11% growth to exceed $23 Bn by 2024

SELLBYVILLE, Del., Nov. 22, 2017 /PRNewswire-iReach/ -- Patient Handling Equipment Market is expected... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017

FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses in some patients

SILVER SPRING, Md., Nov. 22, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery... Read more ››

By: PR Newswire Association LLC. - 22 Nov 2017
Related companies:  U.S. Food and Drug Administration
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑